These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17991211)

  • 21. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
    Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
    Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Energy intake and energy expenditure profiles in peritoneal dialysis patients.
    Wang AY
    J Ren Nutr; 2011 Jan; 21(1):31-4. PubMed ID: 21195915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary dysfunction is possibly a marker of malnutrition and inflammation but not mortality in patients with end-stage renal disease.
    Yoon SH; Choi NW; Yun SR
    Nephron Clin Pract; 2009; 111(1):c1-6. PubMed ID: 19023220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body mass index, muscle and fat in chronic kidney disease: questions about survival.
    Mafra D; Guebre-Egziabher F; Fouque D
    Nephrol Dial Transplant; 2008 Aug; 23(8):2461-6. PubMed ID: 18390566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of environmental cadmium exposure with inflammation and malnutrition in maintenance haemodialysis patients.
    Hsu CW; Lin JL; Lin-Tan DT; Yen TH; Huang WH; Ho TC; Huang YL; Yeh LM; Huang LM
    Nephrol Dial Transplant; 2009 Apr; 24(4):1282-8. PubMed ID: 19028751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance in chronic uremia.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Barazzoni R
    J Ren Nutr; 2009 Jan; 19(1):20-4. PubMed ID: 19121765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity in chronic kidney disease: good or bad?
    Axelsson J
    Blood Purif; 2008; 26(1):23-9. PubMed ID: 18182791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fighting protein-energy wasting in chronic kidney disease: a challenge of complexity.
    Guarnieri G; Barazzoni R
    J Ren Nutr; 2011 Jan; 21(1):2-6. PubMed ID: 21195908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causes and consequences of inflammation on anemia management in hemodialysis patients.
    Chawla LS; Krishnan M
    Hemodial Int; 2009 Apr; 13(2):222-34. PubMed ID: 19432697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inflammation and nutritional status in haemodialysis patients].
    Tirmenstajn-Janković B; Dimković N; Zivanović M
    Med Pregl; 2007; 60 Suppl 2():137-41. PubMed ID: 18928180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study.
    Chan MR; Young HN; Becker YT; Yevzlin AS
    Semin Dial; 2008; 21(3):274-9. PubMed ID: 18397205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and late outcome of cardiac surgery in dialysis-dependent patients: single-center experience with 245 consecutive patients.
    Rahmanian PB; Adams DH; Castillo JG; Vassalotti J; Filsoufi F
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):915-22. PubMed ID: 18374780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of body protein: energy status in chronic kidney disease.
    Cano NJ; Miolane-Debouit M; Léger J; Heng AE
    Semin Nephrol; 2009 Jan; 29(1):59-66. PubMed ID: 19121475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure.
    Kopple JD
    Am J Clin Nutr; 2005 Jun; 81(6):1257-66. PubMed ID: 15941874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are the anticardiolipin antibodies a risk factor for coronary artery disease in chronic renal failure patients?
    Ucar E; Kuvandik G; Sert M; Kuvandik C; Temizkan A; Borazan A
    Ren Fail; 2008; 30(8):791-5. PubMed ID: 18791953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.